A senior Australian psychiatrist has welcomed a landmark review into the use of puberty blockers and cross-sex hormones for young children experiencing gender dysphoria, saying that it is a “return to evidence-based treatment.”
“I was so relieved to read the Cass Review final report because it signals a return to a careful and evidence-based treatment approach,” psychiatrist Jillian Spencer said in an interview with 2GB.